TTRXTurn Therapeutics Inc.
$6.82
$6.82
$2.7152 weeks$15.28
TTRX in its own filings
Nothing in TTRX's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
45
Events found in the filings · across 120 filings · the record starts in 2025
- Hard flags
- none
Hard flags
- Most recent filing
- Oct 7, 2026
Most recent filing · Form 8-K
- Record starts
- Feb 27, 2025
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 12, 2026
- SEC comment-letter activity14 occurrences
- 2025-09-26
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 7, 2026Corporate Presentation October 2026.Regulation FD disclosure · press release
- Sep 10, 2026Turn Therapeutics to Present at Stifel 2026.Regulation FD disclosure · press release
- Sep 9, 2026Turn Therapeutics Appoints Former CDC Director.Regulation FD disclosure · press release
- Aug 18, 2026As previously disclosed, on October 8, 2025, Turn Therapeutics Inc. (the “Company”) issued to GEM Yield Bahamas Limited a warrant (the “Warrant”) to purchase 1,192,207 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), representing 4% of the Company’s fully diluted outstanding …Unregistered sale of equity · Form 8-K
- Aug 12, 2026Turn Therapeutics Provides Corporate Updates.Earnings release · press release
- Jul 28, 2026Corporate Presentation July 2026.Regulation FD disclosure · press release
- Jul 7, 2026Turn Therapeutics Announces Final Stage 2 Design.Regulation FD disclosure · press release
- Jun 3, 20262026 Jefferies Global Healthcare Conference June 2026.Regulation FD disclosure · press release
- Jun 1, 2026Turn Therapeutics Reports Interim Analysis Findings.Regulation FD disclosure · press release
- May 27, 2026Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36.Regulation FD disclosure · press release
- May 19, 2026Turn Therapeutics to Present at Jefferies Global.Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Biotechnology
The closest names by size in the same industry